美国基因与细胞治疗学会第13届年会。

Idrugs Pub Date : 2010-07-01

Gaetano Romano

{"title":"美国基因与细胞治疗学会第13届年会。","authors":"Gaetano Romano","doi":"","DOIUrl":null,"url":null,"abstract":"The American Society of Gene & Cell Therapy's 13th Annual Meeting, held in Washington, DC, included topics covering new developments in the field of gene therapy. This conference report highlights selected presentations on adenoviral therapies for the treatment of cancer, HIV immunotherapies and gene/cell therapies for the treatment of genetic disorders. Investigational drugs discussed include the TAG vaccine and INGN-007 (both Gradalis Inc), AdCD40L (Uppsala University), Ad5-SSTR/TK-RGD (University of Alabama at Birmingham), CGTG-102 (Oncos Therapeutics Ltd) and lexgenleucel-T (VIRxSYS Corp).","PeriodicalId":55031,"journal":{"name":"Idrugs","volume":"13 7","pages":"444-7"},"PeriodicalIF":0.0000,"publicationDate":"2010-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"American Society of Gene & Cell Therapy--13th Annual Meeting.\",\"authors\":\"Gaetano Romano\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The American Society of Gene & Cell Therapy's 13th Annual Meeting, held in Washington, DC, included topics covering new developments in the field of gene therapy. This conference report highlights selected presentations on adenoviral therapies for the treatment of cancer, HIV immunotherapies and gene/cell therapies for the treatment of genetic disorders. Investigational drugs discussed include the TAG vaccine and INGN-007 (both Gradalis Inc), AdCD40L (Uppsala University), Ad5-SSTR/TK-RGD (University of Alabama at Birmingham), CGTG-102 (Oncos Therapeutics Ltd) and lexgenleucel-T (VIRxSYS Corp).\",\"PeriodicalId\":55031,\"journal\":{\"name\":\"Idrugs\",\"volume\":\"13 7\",\"pages\":\"444-7\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2010-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Idrugs\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Idrugs","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

美国基因与细胞治疗学会第13届年会在华盛顿特区举行，主题涵盖了基因治疗领域的新发展。本会议报告重点介绍了用于治疗癌症的腺病毒疗法、用于治疗遗传疾病的HIV免疫疗法和用于治疗遗传疾病的基因/细胞疗法。讨论的研究药物包括TAG疫苗和INGN-007(均为Gradalis公司)、AdCD40L(乌普萨拉大学)、Ad5-SSTR/TK-RGD(阿拉巴马大学伯明翰分校)、CGTG-102 (Oncos Therapeutics公司)和lexgenleucel-T (VIRxSYS公司)。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

微信好友朋友圈 QQ好友复制链接

本刊更多论文

American Society of Gene & Cell Therapy--13th Annual Meeting.

The American Society of Gene & Cell Therapy's 13th Annual Meeting, held in Washington, DC, included topics covering new developments in the field of gene therapy. This conference report highlights selected presentations on adenoviral therapies for the treatment of cancer, HIV immunotherapies and gene/cell therapies for the treatment of genetic disorders. Investigational drugs discussed include the TAG vaccine and INGN-007 (both Gradalis Inc), AdCD40L (Uppsala University), Ad5-SSTR/TK-RGD (University of Alabama at Birmingham), CGTG-102 (Oncos Therapeutics Ltd) and lexgenleucel-T (VIRxSYS Corp).

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊